Navigation Links
Riordan Lewis & Haden | Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
Date:8/3/2012

LOS ANGELES, Aug. 3, 2012 /PRNewswire/ -- Riordan Lewis & Haden | Equity Partners (RLH) is pleased to announce its acquisition of DCRX Infusion, a leading provider of customized nutritional therapy to patients with end stage renal disease.  DCRX, based in Sunrise, Florida, provides products and services to dialysis centers on a nationwide basis.

RLH is privileged to partner in this investment with Robert Funari, an experienced healthcare executive with a successful background in building specialty pharmaceutical companies. Prior to partnering with RLH, Bob was CEO of Crescent Healthcare and of Syncor International. 

According to Michel Glouchevitch, a partner at Riordan Lewis & Haden, "In today's rapidly changing healthcare environment, DCRX is well positioned to continue to achieve significant growth because the Company provides cost-effective clinical care and outstanding service.  With the benefit of Bob Funari's leadership and expertise, DCRX will accelerate its success and improve the quality of life for more dialysis patients."

Robert Funari, CEO of DCRX Infusion added, "I look forward to working with the excellent DCRX team.  Their passion to help dialysis patients, combined with the strategic insight that RLH brings from its 30 year history of helping build high performance service enterprises, are the building blocks which excite me about this outstanding growth opportunity."

DCRX assists dialysis patients who are at higher risk of adverse clinical outcomes because of chronic malnutrition.  The Company's skilled clinicians work with referring nephrologists to formulate and deliver the appropriate parenteral nutrition therapy for each patient.  DCRX also provides a team of pharmacists, nurses, and dieticians that offer comprehensive clinical consulting support for dialysis centers and their patients.  Through this combination of customization and responsive service, the Company has achieved exceptional growth.

Skyline Global Partners, a Chicago-based private equity firm, also participated in the DCRX Infusion investment.

About RLH

Riordan, Lewis & Haden is a leading private equity firm based in Southern California which invests in high growth, lower middle market, enterprises. Focused on business services, healthcare, and government services, RLH has a demonstrated track record of consistent success over the past 30 years. RLH provides capital and assists portfolio company management teams as they navigate the opportunities and challenges of rapid growth. The firm currently manages over $600 million of assets and is actively seeking new portfolio companies.

Contact:
For more information please contact:

Michel Glouchevitch
Partner
Riordan Lewis & Haden | Equity Partners

310-405-7203
mg@rlhequity.com

Visit us online:

www.rlhequity.com

 

 


'/>"/>
SOURCE Riordan Lewis & Haden | Equity Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
2. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
3. Austin Recovery Becomes Learning Environment for Texas A&M Health Science Center Medical Students
4. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
5. Vaginal Mesh Lawsuits Pick Up Momentum, According To Pulaski & Middleman, LLC
6. Lippincott Williams & Wilkins Launches Electronic Health Record (EHR) Learning Tool to Help Future Nurses Prepare for New Practice Requirements
7. Verenium To Present At The Jefferies 2012 Global Industrial And Aerospace & Defense Conference
8. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
9. United Seating & Mobility Completes Acquisition of Active American Mobility
10. Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications
11. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):